Ross Levine

Ross Levine

Director/Board Member presso QIAGEN N.V.

Patrimonio netto: 716 483 $ in data 31/03/2024

52 anni
Health Technology
Consumer Services
Health Services

Profilo

Ross L.
Levine
is the founder of Ajax Therapeutics, Inc. (founded in 2019) where he holds the title of Director.
He is currently working as an Independent Director at Medicus Sciences Acquisition Corp.
since 2021, as an Independent Member-Supervisory Board at QIAGEN NV since 2016, as a Member-Supervisory Board at QIAGEN GmbH, as a Professor at Weill Cornell Medical College since 2007, and as a Member-Supervisory Board at QIAGEN Srl.
Dr. Levine has previously worked as the Chief-Molecular Cancer Medicine Services at Memorial Sloan Kettering Cancer Center from 2018 to 2022 and as a Scientific Advisor at eFFECTOR Therapeutics, Inc. Dr. Levine holds a doctorate degree from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
29/02/2024 16 738 ( 0.01% ) 716 483 $ 31/03/2024

Posizioni attive di Ross Levine

SocietàPosizioneInizio
QIAGEN N.V. Director/Board Member 01/01/2016
MEDICUS SCIENCES ACQUISITION CORP. Director/Board Member 12/02/2021
Director/Board Member -
Weill Cornell Medical College Corporate Officer/Principal 01/01/2007
Director/Board Member -
Founder 01/01/2019
Tutte le posizioni attive di Ross Levine

Precedenti posizioni note di Ross Levine

SocietàPosizioneFine
Corporate Officer/Principal -
EFFECTOR THERAPEUTICS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Ross Levine

Formazione di Ross Levine

The Johns Hopkins University School of Medicine Doctorate Degree
Harvard College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ross Levine

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
QIAGEN N.V.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

Aziende private5

Health Services

Commercial Services

Health Technology

Health Technology

Finance

Vedi le connessioni aziendali